UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Hepatology (Baltimore, Md.), 2019-01, Vol.69 (1), p.394-419

2019

Volltextzugriff (PDF)

Primary biliary cirrhosis

The Lancet (British edition), 2015-10, Vol.386 (10003), p.1565-1575

2015

Volltextzugriff (PDF)

Primary sclerosing cholangitis

The Lancet (British edition), 2013-11, Vol.382 (9904), p.1587-1599

2013

Volltextzugriff (PDF)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

World journal of gastroenterology : WJG, 2019-02, Vol.25 (6), p.659-671

2019

Volltextzugriff (PDF)

Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Hepatology (Baltimore, Md.), 2022-04, Vol.75 (4), p.1012-1013

2022

Volltextzugriff (PDF)

Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management

Gastroenterology (New York, N.Y. 1943), 2013-09, Vol.145 (3), p.521-536

2013

Volltextzugriff (PDF)

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Academic medicine, 2011-01, Vol.86 (1), p.43-47

2011

Volltextzugriff (PDF)

Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis

Hepatology (Baltimore, Md.), 2008-10, Vol.48 (4), p.1106-1117

2008

Volltextzugriff (PDF)

High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

Hepatology (Baltimore, Md.), 2009-09, Vol.50 (3), p.808-814

2009

Volltextzugriff (PDF)

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Gastroenterology (New York, N.Y. 1943), 2005-07, Vol.129 (1), p.113-121

2005

Volltextzugriff (PDF)

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Clinical gastroenterology and hepatology, 2019-08, Vol.17 (9), p.1894-1901.e1

2019

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease

Annals of epidemiology, 2007-11, Vol.17 (11), p.863-869

2007

Volltextzugriff (PDF)

A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis

Hepatology communications, 2022-07, Vol.6 (7), p.1589-1597

2022

Volltextzugriff (PDF)

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis

BioMed research international, 2013-01, Vol.2013 (2013), p.1-7

2013

Volltextzugriff (PDF)

Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo‐controlled trial

Hepatology (Baltimore, Md.), 2009-12, Vol.50 (6), p.1818-1826

2009

Volltextzugriff (PDF)

Risk factors and comorbidities in primary biliary cirrhosis : A controlled interview-based study of 1032 patients

Hepatology (Baltimore, Md.), 2005-11, Vol.42 (5), p.1194-1202

2005

Volltextzugriff (PDF)

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

Gastroenterology (New York, N.Y. 1943), 2003-08, Vol.125 (2), p.437-443

2003

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease

Journal of gastroenterology and hepatology, 2002-02, Vol.17 (s1), p.S186-S190

2002

Volltextzugriff (PDF)

Autoimmune hepatitis: a review

Journal of gastroenterology, 2012-05, Vol.47 (5), p.498-503

2012

Volltextzugriff (PDF)

An update on cancer risk and surveillance in primary sclerosing cholangitis

Liver international, 2017-08, Vol.37 (8), p.1103-1109

2017

Volltextzugriff (PDF)

Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications

Annals of hepatology, 2017-11, Vol.16 (6), p.835-841

2017

Volltextzugriff (PDF)

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial

Hepatology (Baltimore, Md.), 2004-03, Vol.39 (3), p.770-778

2004

Volltextzugriff (PDF)

An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort

Journal of gastroenterology, 2020-05, Vol.55 (5), p.523-532

2020

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease and the Coronary Artery Disease

Digestive diseases and sciences, 2011-01, Vol.56 (1), p.35-45

2011

Volltextzugriff (PDF)

1 – 25 von 592

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)

Publikationsform

Artikel
(393)
Buchkapitel
(185)
Reviews
(7)
Bücher
(6)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(250)
Life Sciences & Biomedicine
(248)
Humans
(220)
Gastroenterology & Hepatology
(208)
Female
(135)
Male
(134)
Middle Aged
(120)
Adult
(109)
Biological And Medical Sciences
(104)
Medical Sciences
(104)
Aged
(69)
Gastroenterology. Liver. Pancreas. Abdomen
(68)
Other Diseases. Semiology
(62)
Gastroenterology And Hepatology
(60)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(59)
Ursodeoxycholic Acid - Therapeutic Use
(56)
Hepatology
(47)
Liver Cirrhosis, Biliary - Drug Therapy
(45)
Liver Transplantation
(43)
Gastroenterology
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Primary biliary cirrhosis

Primary sclerosing cholangitis

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis

High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study

Nonalcoholic Fatty Liver Disease

A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis

Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo‐controlled trial

Risk factors and comorbidities in primary biliary cirrhosis : A controlled interview-based study of 1032 patients

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

Non-alcoholic fatty liver disease

Autoimmune hepatitis: a review

An update on cancer risk and surveillance in primary sclerosing cholangitis

Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial

An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort

Nonalcoholic Fatty Liver Disease and the Coronary Artery Disease

Aktive Filter

Suchergebnisse filtern